tiprankstipranks
Statera BioPharma (STAB)
OTHER OTC:STAB
US Market

Statera BioPharma (STAB) Income Statement

Compare
189 Followers

Statera BioPharma Income Statement

Last quarter (Q3 2022), Statera BioPharma's total revenue was $670.47K, an increase of 183.48% from the same quarter last year. In Q3, Statera BioPharma's net income was $-5.16M. See Statera BioPharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 21Dec 20Dec 19Dec 18
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -488.31K$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 28.83M$ 10.50M$ 2.81M$ 5.94M
Depreciation and Amortization
$ 255.57K$ 947.00$ 13.78K$ 18.18K
EBITDA
$ 38.93M$ -2.59M$ -2.36M$ -4.80M
Operating Income
$ -98.34M$ -10.50M$ -2.81M$ -4.80M
Other Income/Expenses
$ -3.53M$ -1.59M$ -409.85K$ 1.19M
Pretax Income
$ -101.88M$ -12.09M$ -3.22M$ -3.61M
Net Income
$ -174.41M$ -13.22M$ -3.35M$ -3.61M
Per Share Metrics
$ ―$ ―$ ―$ ―
Basic EPS
$ -4.97$ -0.52$ -0.13$ -0.32
Diluted EPS
$ -4.97$ -0.52$ -0.13$ -0.32
Weighted Average Shares Outstanding
35.11M 25.65M 25.65M 11.29M
Weighted Average Shares Outstanding (Diluted)
35.11M 25.65M 25.65M 11.29M
Currency in USD

Statera BioPharma Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis